The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U ...

Abbott (NYSE: ABT) received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo ...

Abbott has secured the US Food and Drug Administration (FDA) and CE Mark approvals for its Amplatzer Piccolo delivery system, ...

MINNEAPOLIS, Feb. 11 AGA Medical Corporation ("AGA")announced today it received European CE Mark approval for the AMPLATZER(R)Duct Occluder II ("ADO II"). AGA also announced the immediate availability ...

AbbottABT recently has initiated a U.S. pivotal clinical study to evaluate the safety and effectiveness of a modified version of its AMPLATZER device. This device is designed to correct a common ...

MINNEAPOLIS, Jan. 7 AGA Medical Corporation ("AGAMedical") announced today that it received approval from the Japanese Ministryof Health, Labour and Welfare (MHLW) for its AMPLATZER(R) Duct Occluder ...

Complex Left Atrial Appendage Occlusion With a Combination of Amplatzer Amulet Left Atrial Appendage Occluder, Amplatzer Vascular Plug and Vascular Coil Receive the the latest news, research, and ...

ABBOTT PARK, Ill., Aug. 30, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data from the Amulet™ LAA Occluder IDE trial, a multi-center, head-to-head study comparing the company ...

Initial results from more than 800 atrial fibrillation patients presented at Transcatheter Cardiovascular Therapeutics 2016 indicate the AMPLATZER™ Amulet™ LAA Occluder is a safe alternative to ...

Extract or Jail? A Case Report on Transcatheter Tricuspid Valve Replacement in the Presence of Pacemaker Lead Related Tricuspid Regurgitation and Complex Anatomy Receive the the latest news, research, ...

Abbott ABT recently has initiated a U.S. pivotal clinical study to evaluate the safety and effectiveness of a modified version of its AMPLATZER device. This device is designed to correct a common ...